Thus, continuous signaling of TLR 7/9 was responsible for the reduced efficacy of glucocorticoids at inhibiting the IFN pathway in SLE patients and lupus-prone mouse strains (Guiducci et al. 2010). The gene discussed is IFNA1; the disease is systemic lupus erythematosus.